In our 2012-2013 Seed Grant Program Alexander Tzatsos, MD, PhD, was a recipient of a $50,000 award to study the epigenetics of pancreatic cancer. We are pleased to announce he has just received more than $1 million in funding from National Institute of Health (NIH). This recognition of Dr. Tzastos’s work is another positive outcome for our investment towards the cure!
Dr. Tzastos shared his appreciation with us. “We are really happy and fortunate that we secured significant funding to study pancreatic cancer for the next 3-4 years. In fact, this is largely due to the seed grant from the Hirshberg Foundation that allowed us to take the risk and generate all the necessary preliminary data to submit those successful applications.”
The Hirshberg Seed Grant Program began in 2000 to provide start-up funds for scientists with innovative ideas for improving diagnosis, developing new treatment modalities and to impact the understanding of pancreatic cancer cell biology. To date, we estimate $45 million in government funding received from our selected awardees. We thank our distinctive Scientific Advisory board for their outstanding collaboration.
Our next grant cycle begins on August 15, 2014 and we expect more qualified applicants than ever before. We need your continued support to take us another step closer to a pancreatic cancer-free life!
